The presence of idiotype-reactive T-cell subsets and their relation to
the tumor load were analyzed in 9 patients with monoclonal gammopathy
of undetermined significance (MGUS), in 12 patients with multiple mye
loma (MM) clinical stage I, and in 9 patients with MM stage II/III. An
enzyme-linked immunospot assay was used to identify interferon-gamma
(IFN-gamma)-, interleukin-2 (IL-2)-, or IL-4-secreting T cells after s
timulation by F(ab')(2) fragments of monoclonal IgG. The response to a
utologous IgG was significantly higher than that induced by isotypic m
onoclonal IgG. Comparable results were obtained in a proliferation ass
ay (H-3-thymidine incorporation). A total of 8 of 9 patients with MGUS
, 7 of 12 patients with MM stage I, and 3 of 9 with MM stage II/III ha
d T cells secreting IFN-gamma and/or IL-2 (T helper [Th1] type-1 cells
), whereas cells secreting both Th1 and Th2 or Th0 types of cytokines
were more frequent in patients with MM, particularly in those with MM
stage II/III. The number and frequency of Th1-type cells were signific
antly higher in MGUS patients as compared with those of MM stage II/II
I. The T-cell response was inhibited by an anti-DR antibody. The resul
ts indicate that idiotype-reactive T cells of the Th1 and Th2 or Th0 s
ubsets were present in MGs and might provide indirect evidence that id
iotype-reactive Th1-type cells may have a regulatory impact on the hum
an tumor B cells. (C) 1995 by The American Society of Hematology.